These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Contribution on the study of pseudohypertrophic muscular dystrophies. I. Benign pseudohypertrophic muscular dystrophy]. Radu H; Stenzel K Dtsch Z Nervenheilkd; 1969; 196(2):92-115. PubMed ID: 5800957 [No Abstract] [Full Text] [Related]
8. Dysferlin and muscular dystrophy. Bushby KM Acta Neurol Belg; 2000 Sep; 100(3):142-5. PubMed ID: 11098285 [TBL] [Abstract][Full Text] [Related]
9. The comparative utility of serum creatine kinase versus serum aldolase in the evaluation of muscle disorders. Giesker D; Bowers GN Conn Med; 1979 Nov; 43(11):699-704. PubMed ID: 389542 [No Abstract] [Full Text] [Related]
10. Disturbances of amino acid metabolism in clinical syndromes not characterised by a primary amino acidopathy. Bremer HJ; Przyrembel H Clin Endocrinol Metab; 1974 Mar; 3(1):131-43. PubMed ID: 4609644 [No Abstract] [Full Text] [Related]
11. Some biochemical changes occurring in muscular dystrophy and their possible genetical significance. Monckton G; Nihei T Ann N Y Acad Sci; 1966 Sep; 138(1):329-41. PubMed ID: 5230213 [No Abstract] [Full Text] [Related]